Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000521946 | SCV000618871 | uncertain significance | not provided | 2017-06-27 | criteria provided, single submitter | clinical testing | The S5432Y variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. The S5432Y variant is not observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). This variant is a semi-conservative amino acid substitution, which may impact secondary protein structure as these residues differ in some properties. However, this substitution occurs at a position that is not conserved and the majority of pathogenic variants in the TTN gene are loss of function and result from truncating variants. Additionally, the S5432Y variant is not located in the A-band nor the M-line region of titin, where the majority of pathogenic truncating variants have been reported. In silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. |
Ce |
RCV000521946 | SCV004033829 | uncertain significance | not provided | 2023-08-01 | criteria provided, single submitter | clinical testing | TTN: PM2, BP4 |